Equifax (NYSE:EFX) Issues FY24 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $7.25-7.35 for the period, compared to the consensus earnings per share estimate of $7.36. The company issued revenue guidance of $5.70-5.72 billion, compared to the consensus revenue estimate of $5.73 billion. Equifax also updated its FY 2024 guidance to 7.250-7.350 EPS.

Analyst Ratings Changes

A number of brokerages have commented on EFX. The Goldman Sachs Group increased their price target on shares of Equifax from $277.00 to $307.00 and gave the company a “neutral” rating in a research report on Tuesday, August 20th. Morgan Stanley raised their price objective on Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a research note on Thursday, September 12th. Barclays boosted their target price on Equifax from $300.00 to $380.00 and gave the company an “overweight” rating in a research note on Friday, September 13th. Stifel Nicolaus raised their price target on Equifax from $265.00 to $305.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Finally, Robert W. Baird boosted their price objective on Equifax from $260.00 to $290.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $307.74.

Equifax Stock Performance

Shares of EFX stock opened at $289.95 on Thursday. The company’s fifty day moving average price is $294.89 and its 200-day moving average price is $262.68. The stock has a market cap of $35.84 billion, a PE ratio of 64.58, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 1.01. Equifax has a 12 month low of $159.95 and a 12 month high of $309.63.

Equifax (NYSE:EFX) last released its earnings results on Wednesday, July 17th. The credit services provider reported $1.82 EPS for the quarter, topping the consensus estimate of $1.73 by $0.09. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the previous year, the company posted $1.71 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, equities analysts expect that Equifax will post 7.36 EPS for the current fiscal year.

Equifax Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Tuesday, September 3rd were issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date was Tuesday, September 3rd. Equifax’s payout ratio is 34.74%.

Insiders Place Their Bets

In other news, EVP Carla Chaney sold 3,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total transaction of $845,550.00. Following the transaction, the executive vice president now directly owns 10,875 shares of the company’s stock, valued at $3,065,118.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.57% of the company’s stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.